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Objective: To explore the regulatory role of thioredoxin-interacting protein (TXNIP) in
Wnt/b-catenin signaling pathway and therefore to elucidate its function in diabetic
myocardial infarction.
Methods: Diabetic myocardial infarction models were generated in mice. The
expression levels of TXNIP and b-catenin and level of reactive oxygen species (ROS)
were determined and compared with those in control group. Human umbilical vein
endothelial cells were treated with high-concentration glucose and/or silencing
TXNIP and/or H2O2. After 24 h, expression levels of TXNIP, b-catenin and its
downstream protein Cyclin D1, and C-myc gene were determined by real-time PCR,
Western blot and immunoﬂuorescence method. The cell proliferation and ROS pro-
duction capability in different groups were determined by methyl thiazolyl tetrazo-
lium assay.
Results: Compared with control group, hyperglycemia signiﬁcantly up-regulated TXNIP
expression and ROS level in the myocardium and endothelial cells of myocardial
infarction area, whereas the b-catenin expression was down-regulated, and the difference
was statistically signiﬁcant (P < 0.05). In comparison with Human umbilical vein
endothelial cells in the control group, high glucose level increased the levels of TXNIP
expression and ROS level in cells, but reduced cell proliferation as well as migration
capability and expression levels of b-catenin, Cyclin D1 and C-myc; the difference was
statistically signiﬁcant (P < 0.05). However, this trend can be partially reversed by
silencing TXNIP.
Conclusions: Diabetic myocardial ischemia could up-regulate levels of TXNIP
expression and ROS production in endothelial cells of myocardial infarction area.
The regulation effect of TXNIP on b-catenin was partially achieved by changing ROS
levels.1. Introduction
At present, there are more than 300 million diabetes patients
all around the world and the number would reach near 400
million till 2025 [1]; in addition, more than 400 million people
are at stake of prediabetic state [2]. In China, there are near 90million diabetes patients [3], nearly accounting for 1/3 of the
globe. Obviously, diabetes has become the major factor for
inﬂuencing the people's health in both China and around the
world [4,5]. Researches show that diabetes can raise the
morbidity of cardiovascular and cerebrovascular diseases in
patients [6], and increase the occurrence rate of myocardial
infarction, heart failure, death and others [7]. Therefore, it is of
great signiﬁcance to study the action mechanism of diabetes in
myocardial infarction and other diseases, as well as the
signiﬁcance of treatment in improving the patients' health state
and decreasing the incidence rate of cardiovascular diseases.
The formation of coronary collateral circulation and angio-
genesis is a kind of compensatory protection mechanism sec-
ondary to myocardial ischemia. Meier et al found that branchingcess article under the CC BY-NC-ND
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patients with coronary artery disease [8]. However, diabetes has
an inhibitory effect on the formation of coronary collateral
circulation [9,10], which may be the important reason for the
high incidence rate of cardiovascular disease and other illness
in diabetes patients. In the other hand, the scarce study on the
relative internal mechanism is not good for the deﬁnition of
pathogenesis of diabetes as well as the treatments for it.
Researches show that Wnt/b-catenin signaling pathway is of
signiﬁcance in cell proliferation, angiogenesis, cardial
development and repair, etc [11–13]. Thioredoxin-interacting
protein (TXNIP) is a sort of protein playing an important role
in the development of diabetes, whose expression can be regu-
lated by the blood glucose levels [14]. Nevertheless, there are no
relevant reports about what kind of connection exists between
TXNIP and Wnt/b-catenin signaling pathway, and how they
play a regulatory role in diabetic myocardial infarction. The
present study generated the diabetic myocardial infarction
models in rats for the analysis of changes in TXNIP, as well
as b-catenin and its downstream proteins Cyclin D1, and
human umbilical vein endothelial cells (HUVEC) for the
analysis of changes in c-Myc and reactive oxygen species
(ROS) after high concentrations of glucose treatment,
respectively, to explore the action mechanism of TXNIP and
Wnt/b-catenin signaling pathway as well as their roles in
diabetic myocardial infarction, so as to provide the scientiﬁc
reference for treating diabetic myocardial infarction through
TXNIP.
2. Materials and methods
2.1. Experimental materials
Male C57BL/6 rats aged 8 wk and weighed 20 g were pur-
chased from Shanghai WuXi AppTec Incorporation and raised
and domesticated in the experimental conditions for a week
before the experiment. The temperature and circadian rhythms
and other factors were maintained constant, and good ventilation
was achieved during the period of domestication.
HUVEC was purchased from Nanjing KeyGEN Biotech.
Co., LTD and raised in an incubator with 5% CO2 and dul-
becco's modiﬁed eagle medium at 37 C.
2.2. Experiment design
2.2.1. Animal handling
Rats with the same age and similar weights were starved for
12 h. Some of them were treated with intraperitoneal injection of
50 mg/kg streplozotocin to generate the diabetes models. If
higher than 11 mmol/L blood glucose of was observed for
continuous 3 d, then it meant the modeling was successful, and
the rats were continued to be raised for a month.
The rats which were not generated into diabetes models and
the diabetes models which were raised after a month were
treated as follows respectively:
Ⅰ: Non-diabetes + sham operation (NS); Ⅱ: Non-
diabetes + myocardial infarction (NMI); Ⅲ: Diabetes + sham
operation (DS); Ⅳ: Diabetes + myocardial infarction (DMI).The rats with myocardial infarction were ﬁxed on the labo-
ratory table after 2% isoﬂurane anesthesia, and the thoracic
cavity was cut off carefully. The left anterior descending coro-
nary artery was ligatured at the inferior position of left auricle
with 6/0 no damage suture line, and then the heart was put back
and the chest was closed. The rats treated with sham operation
were in the same situation without the ligatured left anterior
descending coronary artery though.
After the treatment, the rats in each group were raised for 4 d
until their hearts were taken out to clip the myocardial infarction
tissue for determination of the expression level of TXNIP, ROS
production and other indicators.
2.2.2. Cell handling
After the HUVEC was cultured to the fourth generation, cells
at logarithmic phase were digested with 0.25% pancreatic
enzyme and inoculated in a 6-well plate. Then, 33 mmol/L
glucose or culture of 33 mmol/L glucose + [H2O2 and/or
silencing TXNIP (siTXNIP)] was added as follows:
a) 5.5 mmol/L glucose (control); b) 33 mmol/L glucose; c)
33 mmol/L glucose + siTXNIP; d) 33 mmol/L glucose + H2O2;
e) 33 mmol/L glucose + H2O2 + siTXNIP.
For each handling, 5 repetitive wells were established and
24 h after the handling, the culture was abandoned. TXNIP and
b-catenin expression levels in cells, ROS production and other
indicators were determined.
2.3. Determination of experimental indicators
2.3.1. Determination of protein expression in heart
tissue and HUVEC
The expression levels of TXNIP and b-catenin in heart tissue
and HUVEC were determined by Western blot. After the
experiment, myocardial infarction tissue or handled cells in each
group was taken, and radio-immunoprecipitation assay lysis
buffer was added and then the mixture was lay on the ice to
undergo lysis for 30 min. After 10-min centrifugation at 4 C
and 12000 r/min, the supernatant was collected. Through so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis, the
proteins in samples were separated and transferred to poly-
vinylidene diﬂuoride. The 5% skimmed milk powder was used
to seal polyvinylidene diﬂuoride and then corresponding pri-
mary antibody was added and kept at 4 C overnight before tris
buffered saline tween was used to wash the membrane. Then, the
corresponding second antibody was added (1:3000) and incu-
bated at room temperature for 1 h. After the second membrane
washing with tris buffered saline tween, ECL-plus luminescence
liquid was used for rendering color. The relative expression was
expressed by the speciﬁc value of gray levels of protein bands
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
bands.
2.3.2. Determination of ﬂuorescence levels of TXNIP in
heart tissue and HUVEC
After the experiment, 5 rats in each group were dissected.
The hearts were OCT-embedded and frozen with liquid nitrogen,
after which frozen sections were cut and kept at −20 C. For
HUVEC, cells were collected; and after culture medium was
Table 1
The primers sequence in this experiment.
Primers Sequence
TXNIP F 50-CAGAAGCTCCTCCCTGCTATATG-30
R 50-GATGCAGGGATCCACCTCAG-30
Cyclin D1 F 50-TCTACACCGACAACTCCATCC-30
R 50-GTGTTTGCGGATGATCTGTTT-30
C-myc F 50-CCTCCACTCGGAAGGACTATC-30
R 50-TGTTCGCCTCTTGACATTCTC-30
GAPDH F 50-GACCTGACCTGCCGTCTA-30
R 50-AGGAGTGGGTGTCGCTGT-30
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10 min and then washed.
Upon determination, the frozen sections were taken out and
rewarmed at temperature for 30 min. Then, 3‰ goat serum was
added into frozen sections, or HUVEC that was frozen with
paraformaldehyde for sealing treatment for 1 h. Afterwards,
mixed primary antibody [rat CD31 monoclonal antibody
(endothelial cell marker) and rat TXNIP monoclonal antibody]
was added and kept at 4 C overnight. After being rewarmed for
30 min, phosphate buffer (PBS) was used to wash them and
mixed second antibody (goat anti-rat Flour-594 ﬂuorescence
second antibody and goat anti-rat 488 ﬂuorescence second
antibody) was added for sealing treatment for 1.5 h. After sec-
ond washing with PBS, 40,6-diamidino-2-phenylindole was
added. PBS was used to wash them again and 50% glycerinum
was used to seal the sections, after incubation at 37 C for
10 min. Then, laser scanning confocal microscope (Nikon,
Japan) was used to determine the ﬂuorescence level of TXNIP
in endothelial cells of myocardial infarction area. A total of 5
parts of each rat were shot and the TXNIP amount was
calculated.
2.3.3. Determination of cell proliferation and migration
capability of HUVEC
Cells at logarithmic phase were taken to culture with 5%
CO2 at 37 C for 24 h. With reference to the handling in Part
2.2.2., corresponding fresh culture (density of 2 × 104/well)
was used instead and the cells were cultured for 24, 48, 72 and
96 h, after which methyl thiazolyl tetrazolium colorimetry
assay was used to determine the cytoactivity and cellular pro-
liferation inhibition rate was calculated with 5 repetitive wells
established. Upon determination, methyl thiazolyl tetrazolium
(5 g/L) 20 mL was added to each well and the incubation was
continued for 4 h before the culture solution was abandoned.
Then, 15 mL dimethyl sulfoxide was added and the mixture was
shaken for 10 min after which the absorbance was determined
at 490 nm.
2.3.4. Determination of TXNIP, Cyclin D1 and C-myc
mRNA levels in HUVEC
The real-time PCR was used to quantify the levels of
TXNIP, Cyclin D1 and mRNA of C-myc in HUVEC. Upon
determination, a moderate amount of cell samples were taken
and Trizol reagent was added. According to the RNA
extraction kit (Invitrogen, USA) protocol, the total RNA was
extracted and the extracted RNA amount (A260) as well as
purity (A260/A280) was determined. A total of 1 mg total
RNA was taken to reversely transcript to the ﬁrst strand of
cDNA, after which the according primers were added for
ampliﬁcation with GAPDH as the reference gene (Table 1).
The results of ampliﬁcation were analyzed by using 2−DDCt
method.
2.3.5. Determination of ROS
With reference to the method in Part 2.3.2., after the tissue
sections and collected HUVEC were sealed with goat serum, the
ROS ﬂuorescence probe—dihydroethidium, was added and
incubated at 37 C for 1.5 h. After PBS washing and the addition
of 40,6-diamidino-2-phenylindole, the ROS levels in heart andcells were determined by using laser scanning confocal micro-
scope based on the previous method.
2.4. Statistical analysis
Data were expressed as mean ± SD. One-way ANOVA
was conducted by using SPSS20.0 and independent sample
t was used to determine the difference between groups.
Results with P < 0.05 were considered to be statistically
signiﬁcant.
3. Results
3.1. Effect of high glucose on TXNIP in heart tissue
Figure 1 showed that compared with control group, the
expression levels of TXNIP mRNA and proteins in rats’
myocardium in DS group were signiﬁcantly increased, and
TXNIP expression levels in endothelial cells of heart increased,
with statistically signiﬁcant difference (P < 0.05). Compared
with NMI group, the expression levels of TXNIP in myocardial
infarction area and endothelial cells of heart in DMI group were
signiﬁcantly increased, with statistically signiﬁcant difference
(P < 0.05).
3.2. Effect of high glucose on TXNIP expression in
HUVEC
The results of PCR, Western blot and immunoﬂuorescence
method showed in Figure 2 that 24 h after high glucose
treatment, TXNIP expression in HUVEC cells in HG group
was signiﬁcantly higher than that in control group, with sta-
tistically signiﬁcant difference (P < 0.05). Compared with HG
group, TXNIP expression in siTXNIP + HG group signiﬁ-
cantly decreased, with statistically signiﬁcant difference
(P < 0.05).
3.3. Effect of high glucose on cell proliferation and
migration capability of HUVEC
Results of methyl thiazolyl tetrazolium assay showed that
cell proliferation of HUVEC in HG group was signiﬁcantly
lower than that in control and siTXNIP + HG groups, with
statistically signiﬁcant difference (P < 0.05) (Figure 3A).
Figure 3B showed that cell migration capability in HG group
was signiﬁcantly lower than that in control and
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(P < 0.05).
3.4. Effect of high glucose on ROS levels in heart and
HUVEC
Compared with control group, ROS level in heart in DS
group was signiﬁcantly increased and meanwhile ROS level in
DMI was also higher than that in NMI group, with statistically
signiﬁcant difference (P < 0.05) (Figure 4A). Compared with
HUVEC in control group, the ROS level in HG was signiﬁcantly
increased and higher than that in siTXNIP + HG group, with
statistically signiﬁcant difference (P < 0.05) (Figure 4B).Figure 1. TXNIP expression levels in different groups.
A: TXNIP mRNA in myocardium; B, C: TXNIP proteins in myocardium; D, E:
between groups (P < 0.05).3.5. Effect of high glucose on b-catenin in heart and b-
catenin, Cyclin D1 and C-myc expression levels in
HUVEC
Compared with control group, b-catenin expression level in
heart in DS group was signiﬁcantly decreased and meanwhile b-
catenin expression level in DMI group was signiﬁcantly lower
than that in NMI group, with statistically signiﬁcant difference
(P < 0.05) (Figure 5A). Compared with HUVEC in control
group, the expression levels of b-catenin, Cyclin D1 and C-myc
were signiﬁcantly decreased in HG group, and all indicators in
HG group were lower than those in siTXNIP + HG group, with
statistically signiﬁcant difference (P < 0.05).TXNIP in myocardial endothelial cells; *: Statistically signiﬁcant difference
Figure 3. Cell proliferation and migration capability of HUVEC in different groups.
A: Cell proliferation changes; B: Cell migration capability; *: Statistically signiﬁcant difference between HG and control groups (P < 0.05); #: Statistically
signiﬁcant difference between siTXNIP and HG groups (P < 0.05).
Figure 4. ROS levels in HUVEC and heart in different groups.
A: ROS levels in heart; B: ROS levels in HUVEC; *: Statistically signiﬁcant difference between groups (P < 0.05).
Figure 2. TXNIP expression levels in HUVEC in different groups.
A: TXNIP mRNA in HUVEC; B, C: TXNIP protein in HUVEC by Western blot; D, E: TXNIP protein in HUVEC by immunoﬂuorescence
method; *: Statistically signiﬁcant difference between HG and control groups (P < 0.05); #: Statistically signiﬁcant difference between siTXNIP
and HG groups (P < 0.05).
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Figure 5. Expression levels of b-catenin in heart and b-catenin, Cyclin D1 and C-myc in HUVEC in different groups.
A: b-catenin in heart; B, C, D: b-catenin, Cyclin D1 and C-myc in HUVEC; *: Statistically signiﬁcant difference between groups or between HG and control
groups (P < 0.05); #: Statistically signiﬁcant difference between siTXNIP and HG groups (P < 0.05).
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Diabetes is one of the major chronic diseases affecting peo-
ple's health and there have been researches conﬁrming that
diabetes may affect the angiogenesis after occurrence of
myocardial ischemia [15], and inhibit the formation of coronary
collateral circulation [9,10], and these functions are closely
related to endothelial cells. Therefore, researches on effect of
endothelial cells on cardiovascular diseases are of great
signiﬁcance in exploring the pathogenesis of diabetes related
diseases. The present study generated diabetic myocardial
infarction models and HUVEC after high concentration
glucose treatment to analyze and also illustrate the regulatory
mechanism of TXNIP in diabetic myocardial infarction
through Wnt/b-catenin signaling pathway.
As the key regulatory protein in diabetes, the mechanism of
TXNIP has been the research focus in recent years. TXNIP
belongs to the a inhibitory protein whose expression can be
activated in high glucose environment and then the blood
glucose can be regulated [16]. Anu et al reported the high
expression of TXNIP in patients with diabetic nephropathy
[17]; Chai et al reported the close connection between the
regulatory function of melbine on glucose and its inhibition
against the high expression of TXNIP [18]. The present study
ﬁnds that compared with normal rats, diabetes would cause
high expression of myocardial tissue and endothelial cells in
heart and meanwhile the high glucose upregulates the
expression level of TXNIP in HUVEC. All of the results show
the positive correlation between TXNIP expression and
incidence of diabetes. In contrast with rats with non-diabetic
myocardial infarction, the TXNIP expression in myocardial
infarction and heart endothelial cells in diabetes rats were
signiﬁcantly elevated, which may be related to the aggravated
damage induced by myocardial ischemia under the state ofdiabetes. It is further found in the present study that high glucose
signiﬁcantly decreased the proliferation and migration capability
of HUVEC; and siTXNIP can reversely transcripted the inhib-
itory effect of high glucose on proliferation and migration
capability of HUVEC, which conﬁrms the above speculation. It
is clear that the inhibitory effect of TXNIP on proliferation and
migration capability under the state of diabetes may lead to
impaired angiogenesis and further cause myocardial ischemia-
induced damage.
Wnt/b-catenin signaling pathway is important in cell prolif-
eration and others and researches show that this signaling
pathway can be activated after occurrence of myocardial
infarction [19,20], so as to repair the damaged myocardium [21].
Whether the inhibitory effect of TXNIP expression on cell
proliferation is the result of regulatory function of TXNIP
through Wnt/b-catenin signaling pathway? With an aim to
solve the problem, the present study analyzed the hearts of
rats with diabetic myocardial infarction and HUVEC after
high glucose treatment, and found that the b-catenin
expression levels in both heart and HUVEC were signiﬁcantly
lower than those in control group. In the meanwhile, the
downstream protein of b-catenin, Cyclin D1 and C-myc gene
in HUVEC were signiﬁcantly decreased and siTXNIP can
reversely transcript the change. The study results show that
TXNIP expression under the state of diabetes can down-
regulate the activity of b-catenin so that the Wnt/b-catenin
signaling pathway can play a regulatory role in cells.
ROS is the major production of mitochondrial respiration,
whose level changes are important in cellular signal trans-
duction, and occurrence as well as development of atheroscle-
rosis, diabetes and so on [22–24]. Researches show that under the
state of high glucose, TXNIP expression was signiﬁcantly up-
regulated so as to stimulate the cells to produce oxidative
stress, to damage DNA etc [25], and inhibiting TXNIP
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study, diabetes up-regulated TXNIP expression and meanwhile
increased ROS levels in rats and HUVEC, whereas siTXNIP can
inhibit the production of ROS, which indicates that diabetes can
aggravate the production of ROS after the occurrence of
myocardial infarction and at the same time, that the regulatory
function of TXNIP against b-catenin may be partially achieved
through ROS level changes in cells.
In conclusion, the study results show that diabetic myocardial
ischemia can increase the expression of TXNIP in myocardial
infarction area and endothelial cells while the latter can regulate
the b-catenin by changing ROS levels so as to affect the pro-
liferation and migration of endothelial cells of myocardium, and
so forth. As a matter of fact, TXNIP may act on Wnt/b-catenin
signaling pathway through multiple ways including ROS, and
other ways and the mechanisms of action still remain to be
further explored.
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